Prof. Dr. Seock-Ah Im

__Prof. Seock-Ah Im__ is a medical oncologist and Professor of Internal Medicine at Seoul National University Hospital and the Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. She is internationally recognized for her work in translational research and clinical trials in breast cancer, with a special focus in premenopausal hormone-receptor-positive breast cancer, gastric cancer and gastrointestinal stromal tumors (GIST). --- ### Professional Background - __Experience/Years of Work:__ Since 1991 - __Based In:__ Seoul, South Korea --- ### Innovations & Contributions Prof. Im is recognized for "bench-to-clinic" oncology research that has influenced the treatment for advanced breast cancer worldwide. - __Landmark Trials:__ Investigator on the MONALEESA-3 trial and MONALEESA-7 trial that led to FDA approval of ribociclib + endocrine therapy in HR+/HER2– advanced breast cancer (New England Journal of Medicine). - __Research Output:__ Over 1,000 peer-reviewed publications and over 60,000 citations. - Awards: Hamchun Creative Award by Seoul National University for publication of MONALEESA-7 overall survival. - __Leadership:__ Director of Seoul National University Cancer Research Institute (SNU CRI). - __Translational Discoveries:__ Discovered RAD51C deficiency as a predictive marker for the PARP inhibitor olaparib and ATM deficiency as a marker for ATR inhibitor response.